According to the State Drug Administration, from May 28 to 31, Zhao Junning, a member of the party group and deputy director of the State Drug Administration, led a team to Heilongjiang and Liaoning to investigate traditional Chinese medicine supervision work, learn more about the production quality management of proprietary Chinese medicines, intelligent manufacturing development, and the cultivation and cultivation of rare and endangered Chinese herbal medicines, visited relevant Chinese herbal medicine specialty markets, imported herbal medicine ports, and held discussions and exchanges with local drug regulatory authorities, research institutes and business representatives. Zhao Junning said that we should adhere to Xi Jinping's ideology of socialism with Chinese characteristics in the new era, strengthen the inheritance, innovation and development of traditional Chinese medicine, focus on the heritage and resource advantages of the traditional Chinese medicine industry in Liaoning and Heilongjiang, promote the standardized development of Chinese herbal medicines, strengthen the protection of rare wild Chinese herbal medicines, strengthen the supervision of the whole chain of traditional Chinese medicine, accelerate the construction of an excellent supervision system for traditional Chinese medicine, cultivate and develop new quality productivity, and promote the inheritance, innovation and high-quality development of traditional Chinese medicine, and contribute the strength of traditional Chinese medicine to the comprehensive revitalization of Chinese medicine in Northeast China.